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ABSTRACT
Inflammatory myofibroblastic tumor (IMT) is a benign disorder of locally aggressive nature. It is an indolent tumor with a slowly progressive course 
and varied manifestation presenting with a wide range of clinical manifestations depending on the site of origin. We present a case of IMT in the 
maxillary sinus presenting with hemifacial pain, oculomotor palsy and ptosis which was successfully treated with endoscopic local excision and oral 
steroid therapy.
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INTRODUCTION
Inflammatory myofibroblastic tumor (IMT) is a benign disorder of 
locally aggressive nature [1]. This tumor provides a dilemma in diagnosis 
due to the bone-eroding properties and drastic clinical presentation, 
prompting the clinician to favor a diagnosis of malignancy rather than 
an indolent tumor with a chronically progressive course [1,2]. We 
present a case of a 38-year-old man who presented with hemifacial 
pain, oculomotor palsy, and ptosis of short duration which was an 
atypical presentation of this benign pathological entity.
CASE REPORT
A 38-year-old nondiabetic, nonhypertensive man presented to the 
outpatient department with the chief complaints of left hemifacial pain 
for one and a half months and drooping of the left eye of 10 days duration. 
The left hemifacial pain initially began as throbbing, continuous pain 
in the left upper first molar which then progressed to the left cheek 
and the left parietal region. It relieved on taking analgesics. However, 
there were no aggravating factors. Drooping of the left eye started after 
an episode of severe throbbing hemifacial pain. There was no history 
of blurring of vision, diplopia, nausea, vomiting, and fever. There was 
no history of nasal symptoms. He revealed a history of tuberculous 
lymphadenitis 10 years ago and was declared cured after a complete 
course of antitubercular therapy.
Clinical examination revealed swelling in the left maxillary region. 
Diagnostic nasal endoscopy revealed a bulge in the lateral wall of the 
left nasal cavity with no evidence of any mass. Pus was visualized in 
the accessory ostium of the left maxillary sinus. Examination of the eye 
revealed ptosis of left upper eyelid with sluggish pupillary reactions 
and oculomotor nerve palsy, however, the vision was 6/6, and corneal 
reflex was intact. Neurological and other cranial nerve examination 
revealed no abnormalities. Ear, throat, and neck examination was 
normal. Systemic examination was normal.
Blood investigations revealed an elevated erythrocyte sedimentation 
rate of 52 mm/hrs. Contrast-enhanced computed tomography (CECT) 
of the nose and paranasal sinuses showed opacity in the left maxillary 
sinus extending to orbital apex and infratemporal fossa. Magnetic 
resonance imaging (MRI) of the brain and paranasal sinuses revealed 
an ill-defined altered signal intensity lesion involving the left maxillary 
sinus with thickening and sclerosis of the posterolateral wall of the 
left maxillary sinus with an extension of the lesion into masticator 
space involving temporalis and lateral pterygoid muscles. Superiorly, 
the lesion was abutting the floor of the left orbit with extension into 
extraconal and intraorbital space. Posteriorly, the lesion was involving 
the greater wing of the sphenoid with intracranial extension and 
causing pachymeningitis. Focal enhancement at left supraorbital fissure 
was evident with a small degree of proptosis (Fig. 1a and b).
Diagnostic nasal endoscopy and biopsy taken from the left maxillary 
sinus were reported as plasma cell granuloma with no evidence of 
malignancy. Partial endoscopic maxillectomy was done to obtain 
deeper tissue from the mass for immunohistochemistry and definitive 
diagnosis.
Histopathological examination of the mass showed features consistent 
with IMT (Fig. 2a and b).
Ziehl–Neelsen’s staining of the specimen did not reveal any evidence 
of mycobacteria. Immunohistochemistry showed that the tumor cells 
were positive for vimentin and smooth muscle actin (SMA) and negative 
for CD34, anaplastic lymphoma kinase, Ki67 (Fig. 3a and b).
Medical therapy with a tapering dose of oral corticosteroids was given 
over a period of 3 months.
On follow-up after 1½ months, the ptosis of his left eye had significantly 
reduced, and the maxillectomy cavity appeared healthy. On subsequent 
follow-up after 3 months, the ptosis had completely resolved 
(Fig. 4a and b). Follow-up CECT showed a contracted maxillary sinus 
with no enhancement on contrast.
DISCUSSION
Plasma cell granuloma is a benign, space occupying lesion; that is locally 
aggressive [1]. In 1990, Yuan et al. studied this entity on 20 patients and 
coined the term IMT, stressing on the fact that it is just a congregation of 
reactive, nonspecifically differentiated fibroblastic and myofibroblastic 
cells which mimic malignancy clinically and radiologically and is 
comprised infiltrates of inflammatory polymorphous cells, thick-walled 
vessels, and fibrous stroma [2]. The common sites of occurrence are the 
abdomen and pelvis. However, it can occur in the peritoneum, central 
nervous system, bone, and uterus [2-6]. In the head and neck region, the 
most common site of occurrence is the orbit. It can also occur in the true 
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i1.15428
Case Report
6
Asian J Pharm Clin Res, Vol 10, Issue 1, 2017, 5-7
 Rao et al. 
vocal folds, oral cavity, and oropharynx, nasopharynx, parapharyngeal 
space, and paranasal sinuses [2,3,5]. It does not occur in a specific age 
group, although literature reveals a median age group of 47.4 years for 
the occurrence. The pulmonary variant occurs predominantly in young 
adults, and the extrapulmonary variant occurs mostly in adolescents 
and children. It occurs predominantly in females with a ratio of 3:2 [2,3]. 
Approximately, 30 cases of maxillary sinus plasma cell granuloma have 
been reported in the literature.
IMT is not a single entity, variations in histological appearance give it 
some synonyms; namely, plasma cell granuloma, myofibroblastoma, 
inflammatory pseudotumor, inflammatory myofibrohistiocytic tumor, 
xanthogranuloma, mast cell granuloma, and xanthoma [2,7,8].
Etiology of IMT is unknown. Multiple theories have been postulated 
for the development of this tumor. Perrone et al. considered adjacent 
necrosis or infection to be the inciting foci. The role of viral infectious 
agents such as Epstein–Barr virus and human herpes virus-8 has been 
discussed in the literature. Autoimmunity has also been considered 
as an etiological factor. Chronic infection or inflammation leading to 
differentiation of plasma cells is another theory [1,2,5,7]. In our case, 
the history of tuberculous lymphadenitis (chronic granulomatous 
disease), although treated and cured maybe considered as a trigger 
based on the chronic inflammatory theory.
Clinically, IMT is locally aggressive and causes a varied degree of bone 
destruction, unlike other benign conditions; therefore, the patient is 
subjected to multiple biopsies to arrive at this diagnosis. In maxillary 
sinus involvement, it presents with locoregional features such as nasal 
obstruction, epistaxis, cheek swelling and facial deformity, numbness 
due to infraorbital nerve involvement, proptosis and diplopia due 
to orbital involvement and decreased vision due to optic nerve 
involvement. Vagus and hypoglossal nerve involvement have been 
noted with parapharyngeal space involvement. Systemic features such 
as fever, malaise, and weight loss are reported in patients with thoracic 
and abdominal involvement and not in head and neck IMT. IMT does not 
have the property of lymphatic spread although perineural invasion is 
a known property of IMT. Keen et al. suggested perineurofibromatosis 
and Du Vuysere et al. suggested perineural invasion as the causative 
pathogenesis for neural symptoms of IMT. Our patient presented with 
hemifacial pain and ptosis which can be attributable to infraorbital 
nerve and oculomotor nerve involvement by the tumor [1,3,5,6,8,9].
Histopathologically, the characterization of the tumor is based on 
myofibroblasts and inflammatory cells. Identification of this lesion is by 
histopathological examination, however, it is a diagnosis of exclusion as 
this histological picture is very nonspecific and the absence of adequate 
mitoses and atypia does not characterize it as a neoplastic lesion. Fujii 
et al. have classified the tumor into three subsets based on the varied 
quantity of myofibroblasts and the inflammatory cells. The lymphoid 
subset of IMT has lymphocytes predominantly with little fibrosis. The 
granulomatous subset has an admixture of lymphocytes, histiocytes, 
plasma cells, eosinophils, fibroblasts, and myofibroblasts. The 
sclerosing subset predominantly contains fibrotic cells with minimal 
inflammatory cells. Immunohistochemically, the tumor expresses 
vimentin and SMA. Antiactin antibody positivity denotes its origin in 
the muscle. It is immunohistochemically negative to CD68, keratin, 
desmin, S-100, and caldesmon [1,3,5,6,9].
CT and MRI are not diagnostic of the tumor, only aid in identifying the 
extent. CECT demonstrates the homogenous or heterogenous appearance 
of IMT with bony destruction and local invasion with a variably high 
degree of enhancement on contrast. MRI demonstrates a nonhomogenous 
Fig. 1: (a) T1-weighted coronal magnetic resonance image 
showing altered signal density in the left maxillary sinus 
extending into the orbit. (b) T2-weighted coronal magnetic 
resonance image showing altered signal density in the left 
maxillary sinus extending into the orbit
a b
Fig. 2: (a) Proliferating spindly fibroblasts with inflammatory 
cells (H and E staining, ×100). (b) Plasma cells with 
intracytoplasmic Russell bodies (H and E staining, ×400)
a b
Fig. 3: (a) 400× immunohistochemical staining positive for 
vimentin. (b) 400× immunohistochemical staining positive for 
smooth muscle actin
a b
Fig. 4: (a) Pretreatment image showing left maxillary swelling 
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appearance of IMT and an intermediate signal on T2-weighted images 
due to the paucity of protons in fibrous tissue, high N: C ratio and 
increased cellularity. The presence of fibrous tissue in IMT is inversely 
proportional to the intensity on T2-weighted MRI imaging [2,5,6,9,10].
Differential diagnosis of rhinoscleroma, Wegener’s granulomatosis, 
fibrous histiocytoma, fibromatosis, and soft tissue malignancies such 
as spindle cell sarcoma and myxofibrosarcoma needs to be considered 
due to the erosive properties of the lesion. Occasionally, the histological 
appearance of the tumor may resemble plasmacytoma [3,10].
The treatment options depend on the anatomical site and tumor 
morphology. Lymphoid predominant lesions respond well to 
radiotherapy, whereas granulomatous lesions to high dose 
corticosteroids. Sclerosing lesions are more aggressive and show little 
response to either treatment modality. The initial line of management 
of IMT is high-dose oral corticosteroids. Endoscopic surgery, in the form 
of medial maxillectomy, is performed if the response to steroids is poor. 
This aids in diagnosis by providing biopsy specimens and in clearance 
of the tumor. Current literature suggests excision of the tumor followed 
by corticosteroid therapy for 6 months as the best line of management. 
In our case, we performed endoscopic clearance of the tumor followed 
by oral corticosteroid therapy which resulted in complete remission 
of IMT [1,3,5,6,8,9]. Radiotherapy can be employed as therapeutic 
modality instead of oral corticosteroid therapy and has been known to 
produce tumor free survival [11].
IMT is a benign, chronically progressive tumor with a good prognosis 
when treated with combined modality therapy. Literature shows that 
the following treatment, 80% have remained tumor-free for more 
than 2 years. Single-modality therapy with surgery/corticosteroids/
radiotherapy shows complete remission only in 50% of the cases. 
However, it has also been noted that radical procedures do not do 
well when compared to conservative treatment. 25% patients may 
have a local recurrence following surgical removal and 5% distant 
spread [1,2,9]. In our case, the patient has been tumor free for 3 months.
CONCLUSION
IMT is a locally erosive benign lesion mimicking malignancy 
uncommonly occurring in the maxillary sinus. Perineural involvement 
is a characteristic feature of IMT. Histology of the tumor contains 
inflammatory cells and fibroblastic cells. Combined modality therapy 
with oral corticosteroids and surgical excision is the treatment of 
choice.
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